Record Financial Performance
BWXT reported record revenue, adjusted EBITDA, adjusted earnings per share, and free cash flow for 2024, all meeting or exceeding full-year guidance metrics.
Backlog Growth
The company ended 2024 with a backlog of $4.8 billion, up 21% year-over-year due to large contract awards in both operating segments.
Strategic Investments and Acquisitions
Completed the acquisition of A.O.T., expanding the special materials business line, and announced an agreement to acquire Kinectrics Inc., expected to close in mid-2025.
Commercial Operations Growth
Commercial power revenue grew by more than 10% in 2024, with a record backlog of $930 million, up 19%, supporting expectations for another year of double-digit growth.
Medical Revenue Surge
BWXT Medical's revenue grew 23% in 2024, with EBITDA turning more meaningfully positive, driven by CDMO and PET diagnostics business lines.